Argelia Robledo-Calvillo
Aguascalientes, AGU, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-Term Hepatorenal Toxicity Assessment of the Vasopressin Receptor Antagonist Conivaptan in Lewis Rats: Implications for Therapeutic Safety.
Journal: Journal of applied toxicology : JAT
Published: April 13, 2026
N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer.
Journal: Biomedicines
Published: October 07, 2025
Rapid liver self-recovery: A challenge for rat models of tissue damage.
Journal: Life sciences
Published: April 16, 2024
Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment.
Journal: Frontiers in neuroscience
Published: January 05, 2023
Central GPR55 may prevent nicotine reinforcing actions: a preliminary study.
Journal: Acta neurobiologiae experimentalis
Published: October 10, 2022
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling.
Journal: Life sciences
Published: February 26, 2022
Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats.
Journal: Neuroscience letters
Published: April 21, 2021
Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors.
Journal: Journal of ovarian research
Published: March 09, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026